SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-070403
Filing Date
2023-06-12
Accepted
2023-06-12 16:55:10
Documents
1
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318426-7_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2318426-7_4seq1.xml 4 3889
  Complete submission text file 0001104659-23-070403.txt   5269
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341
Business Address
Lefenfeld Michael (Reporting) CIK: 0001826906 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 231008825